Association of Modified‐FOLFIRINOX‐Regimen‐Based Neoadjuvant Therapy with Outcomes of Locally Advanced Pancreatic Cancer in Chinese Population

LESSONS LEARNED. Modification of FOLFIRINOX significantly improves safety and tolerability in Chinese patients with locally advanced pancreatic cancer. Patients with locally advanced pancreatic cancer benefit from neoadjuvant therapy and experience a much better survival than patients with upfront s...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Main Authors: Li, Xiang, Guo, Chengxiang, Li, Qinghai, Wei, Shumei, Zhang, Qi, Chen, Yiwen, Shen, Yinan, Ma, Tao, Li, Guogang, Gao, Shunliang, Que, Risheng, Lou, Jianying, Yu, Risheng, Yuan, Ying, Wei, Qichun, Huang, Pintong, Liang, Tingbo, Bai, Xueli
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Inc. 2018
Assuntos:
Clinical Trial Results
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6519772/
https://ncbi.nlm.nih.gov/pubmed/30459238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0696
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares